Showing results (31-40 of 61) with videos related to

Sort By:
Pageof 7
Chembiochem : a European Journal of Chemical Biology|July 8, 2025
Design and Characterization of Prodrugged Anti-CTLA-4 AntibodiesSayumi Yamazoe, Mary Huber, Srikanth Kotapati, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 27, 2012
Anti-IL-7 receptor-α reverses established type 1 diabetes in nonobese diabetic mice by modulating effector T-cell functionLi-Fen Lee, Kathryn Logronio, Guang Huan Tu, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 11, 2013
High-affinity IgG antibodies develop naturally in Ig-knockout rats carrying germline human IgH/Igκ/Igλ loci bearing the rat CH regionMichael J Osborn, Biao Ma, Suzanne Avis, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 30, 2011
Naive antibody gene-segment frequencies are heritable and unaltered by chronic lymphocyte ablationJacob Glanville, Tracy C Kuo, H-Christian von Büdingen, et al.
The Journal of Biological Chemistry|April 30, 2016
Modulation of P2X3 and P2X2/3 Receptors by Monoclonal AntibodiesAnatoly Shcherbatko, Davide Foletti, Kris Poulsen, et al.
Analytical Chemistry|December 21, 2019
Universal Affinity Capture Liquid Chromatography-Mass Spectrometry Assay for Evaluation of Biotransformation of Site-Specific Antibody Drug Conjugates in Preclinical StudiesSrikanth Kotapati, David Passmore, Sayumi Yamazoe, et al.
The Journal of Biological Chemistry|April 30, 2016
Engineering Highly Potent and Selective Microproteins against Nav1.7 Sodium Channel for Treatment of PainAnatoly Shcherbatko, Andrea Rossi, Davide Foletti, et al.
Mabs|February 22, 2022
Improved therapeutic index of an acidic pH-selective antibodyPeter S Lee, Katherine G MacDonald, Evan Massi, et al.
Nature Communications|November 19, 2016
Germline-encoded neutralization of a Staphylococcus aureus virulence factor by the human antibody repertoireYik Andy Yeung, Davide Foletti, Xiaodi Deng, et al.
Molecular Cancer Therapeutics|September 2, 2016
RN927C, a Site-Specific Trop-2 Antibody-Drug Conjugate (ADC) with Enhanced Stability, Is Highly Efficacious in Preclinical Solid Tumor ModelsPavel Strop, Thomas-Toan Tran, Magdalena Dorywalska, et al.
Pageof 7